Status:
RECRUITING
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Lead Sponsor:
Tianjin Medical University
Collaborating Sponsors:
Tianjin Medical University General Hospital
Conditions:
Amino-Acid Transport Disorder
Primary Hyperparathyroidism
Eligibility:
All Genders
18-90 years
Brief Summary
To evaluate the potential usefulness of 11C/18F-MET/FET positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various amino acid transporter...
Detailed Description
Subjects with various AATS-related disease (Primary Hyperparathyroidism, Glioma, et al) patients underwent 11C/18F-MET/FET PET/CT either for an initial assessment or for recurrence detection. Lesions ...
Eligibility Criteria
Inclusion Criteria:
- adult patients (aged 18 years or order);
- patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report);
- patients who had scheduled AATS PET/CT scan;
- patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Exclusion Criteria:
- patients with non-malignant lesions;
- patients with pregnancy;
- the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Key Trial Info
Start Date :
August 29 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 29 2033
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07379463
Start Date
August 29 2013
End Date
August 29 2033
Last Update
January 30 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China, 230000
2
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China, 300052